Product range includes BPC-157, available as a standalone peptide or in a blended formulation: (1) M.J.Hsieh et al (2016) Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation Journal of Molecular Medicine, 15 November 2016, Volume 95, pages 323333
More on this under point #3 3
Kontrollierte Studien der Phase III, die Wirksamkeit und Sicherheit bei gesunden Erwachsenen ber lngere Zeitrume belegen wrden, existieren nicht
PMID 20607069
For qualified research professionals only
The USADA states: There appears to be no legal basis for selling BPC-157 as a drug, food, or a dietary supplement, and the Food and Drug Administration (FDA) confirmed there is also no legal basis for compounding pharmacies to use BPC-157 in compounded medications